Table 3

Baseline intake of medications in each cohort

N = 251/group

Group A (RA)

Group B (DM)

Group C (GP)

P, all three

P, A versus C


Medications


RA

MTX

126 (50%)

N/A

N/A

--

--

HCQ

92 (37%)

N/A

N/A

--

--

PDN

86 (34%)

N/A

N/A

--

--

TNF

96 (38%)

N/A

N/A

--

--


DM

Insulin

N/A

100 (40%)

N/A

--

--

Metformin

N/A

132 (53%)

N/A

--

--


NSAIDs

74 (29%)

43 (17%)

51 (20%)

0.003

0.02


Anti-HTN

66 (26%)

180 (72%)

86 (34%)

< 0.0001

0.052


Statin

23 (9%)

162 (65%)

38 (15%)

< 0.0001

0.055


ASA

81 mg

22 (9%)

93 (37%)

33 (13%)

< 0.0001

0.12

> 81 mg

5 (2%)

16 (6%)

6 (2%)

0.01

0.76


Anti-HTN, antihypertensives; ASA, aspirin; DM, diabetes mellitus; GP, general population; HCQ, hydroxychloroquine; LEF, leflunomide; MTX, methotrexate; N/A, not applicable; NSAIDs, nonsteroidal antiinflammatory drugs; PDN, prednisone; RA, rheumatoid arthritis; TNF, anti-TNF agents.

Desai et al. Arthritis Research & Therapy 2012 14:R270   doi:10.1186/ar4118

Open Data